Supradiaphragmatic early stage Hodgkin's disease: Does mantle radiation therapy still have a role?

Haematologica

Volumn 81, Issue 2, 1996, Pages 138-142

  Frezza, Giovanni ^a,b   Barbieri, Enza ^a   Zinzani, Pier Luigi ^a   Babini, Lucio ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chemotherapy; Hodgkin's disease; Late toxicity; Radiotherapy; Staging

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; DOSE CALCULATION; EARLY CANCER; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RADIATION DOSE; RADIATION INJURY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

DIAPHRAGM; HODGKIN DISEASE; HUMANS; RADIOTHERAPY;

EID: 0030321626     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Kaplan HD. The radical radiotherapy of regionally localized Hodgkin's disease. Radiology 1962; 78:553-61.
2. Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication and complications. Cancer 1976; 37:2813-25.
3. Cosset JM, Henry Amar M, Meerwaldt JH, et al. The EORTC trials for limited stage Hodgkin's disease. Eur J Cancer 1992; 28:1847-50.
4. Hoppe RS. Radiation therapy in the management of Hodgkin's disease. Semin Oncol 1990; 17:704-15.
5. Levitt SH, Lee CKK, Aeppli D, et al. The role of radiation therapy in Hodgkin's disease: experience and controversy. Cancer 1992; 70:693-703.
6. Rosenberg SA, Kaplan HD. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease 1962-1984. Int J Radiat Oncol Biol Phys 1985; 11:5-22.
7. Lee BJ, Nelson JH, Schwarz G. Evaluation of lymphangiography, inferior venacavography and intravenous pyelography in the clinical staging and management of Hodgkin's disease and lymphosarcoma. N Engl J Med 1964; 271:327-37.
8. Glatstein E, Guernsey JM, Rosenberg SA. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer 1969; 24:709-18.
9. Carbone PP, Kaplan HS, Musshof K. Report of the Committee on Hodgkin's disease staging classification. Cancer Res 1971; 1:1860-1.
10. De Vita VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 92:587-95.
11. Longo DL, Glatstein E, Duffey PL. Radiation therapy versus combination chemotherapy in the treatment of early stage Hodgkin's disease: seven years' results of a prospective randomized trial. J Clin Oncol 1991; 9:906-17.
12. Hoppe RT, Coleman CN, Cox RS, et al. The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood 1982; 59:455-65.
13. Koziner B, Myers J, Cirrincione C, et al. Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities. Am J Med 1986; 80:1067-78.
14. Straus DJ, Yahalom J, Gaynor J, et al. Four cycles of chemotherapy and regional radiation therapy for clinical early stage and intermediate stage Hodgkin's disease. Cancer 1992; 69:1052-60.
15. Sutcliffe SB, Gospodarowicz MK, Bergsagel DE, et al. Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol 1985; 3:393-401.
16. Tubiana M, Henry Amar M, Van der Werf-Messing B, et al. A multivariate analysis of prognostic factors in early stage Hodgkin's disease. Int J Oncol Biol Phys 1985; 11:23-30.
17. Straus DJ. Treatment of early stage Hodgkin's disease. Blood Rev 1993; 7:34-42.
18. Tura S, Canellos G, Goldstone A, et al. Hodgkin's disease: controversies and challenges for the future. Haematologica 1991; 76:263-79.
19. Gospodarowicz MK, Sutcliffe SB, Clark RM, et al. Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone.Int J Radiat Oncol Biol Phys 1992; 22:859-65.
20. Tarbell NI, Thompson L, Mauch P. Thoracic irradiation in Hodgkin's disease:disease control and long term complications. Int J Radiat Oncol Biol Phys 1990; 18:275-81
21. Roach M , Brophy N, Cox R, et al. Prognostic factors for patients relapsing after radiotherapy for early stage Hodgkin's disease. J Clin Oncol 1990; 8:623-9.
22. Santoro A, Viviani S, Villareal CJR, et al. Salvage chemotherapy in Hodgkin's disease after irradiation failures: superiority of doxorubicin-containing regimens over MOPP. Cancer Treat Rep 1986; 70:43-8
23. Leibenhaut MH, Hoppe RT, Efron B, et al. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 1989; 7:81-91.
24. Mauch P, Larson D, Osteen R, et al. Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol 1990; 8:257-65.
25. Meadows AT, Obringer AC, Marrero O, et al. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Ped Oncol 1989 ; 17:477-84.
26. Tura S, Fiacchini M, Zinzani PL, et al. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 1993; 11:925-30.
27. Cosset JM, Henry Amar M, Meerwaldt JH, et al. Long-term toxicity of early stages of Hodgkin's disease therapy. Ann Oncol 1991; 2:77-82.
28. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993; 85:25-31.
29. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993; 11:1208-15.
30. Economoupolos T, Stathakis N, Alexopoulos C, et al. Second malignancies following treatment for Hodgkin's disease: a Greek experience. Haematologica 1994; 79:273-6.
31. Henry Amar M, Somers R. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Semin Oncol 1990; 17:758-68.
32. Longo DL, Duffey PL, Hubbard SM, et al. Radiation therapy is better than chemotherapy in early stage Hogkin's disease? Not so fast. J Clin Oncol 1993; 1367-9.
33. Biti GP, Cimino G, Cartoni C, et al. Extended field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight year update of an Italian prospective randomized study. J Clin Oncol 1992; 8:623-9.
34. Longo DL, Duffey PL, Young RC. Conventional dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy, the low probability of cure. J Clin Oncol 1992; 10:210-8.
35. Hoppe RT. The management of Hodgkin's disease in relapse after primary radiotherapy. Eur J Cancer 1992; 28A:1920-2.
36. Zinzani PL, Barbieri E, Visani G, et al. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high grade non Hodgkin's lymphoma and Hodgkin's disease. Haematologica 1994; 79:508-12.
37. Mazza P, Miniaci G, Lauria F, et al. Prognostic significance of lymphography in stage III S Hodgkin's disease. Eur J Cancer Clin Oncol 1984; 20:1393-9
38. Carde P, Meerwaldt JH, Monconduit M, et al. H6 EORTC controlled trials in clinical stage I-II Hodgkin's disease. First report of a randomized staging laparotomy in favorable cases and of a randomized MOPP versus ABVD combined radiotherapy modality in unfavorable cases (Abstract). Proc Am Soc Clin Oncol 1990; 9:254.
39. Zinzani PL, Barbieri E, Gherlinzoni F, et al. Radiotherapy in early stage Hodgkin's disease. Leuk Lymphoma 1994; 13:285-9.
40. Cosset JM, Henry Amar M, Pellae Cosset B, et al. Pericarditis and myocardial infarction after Hodgkin's disease therapy. Int J Oncol Biol Phys 1991; 21:447-9 .
41. Glanzmann C, Huguenin P, Lutolf UM, et al. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1994; 30:43-54.
42. Pohjola Sintonen S, Totterman KJ, Kupary M. Sick sinus syndrome as a complication of mediastinal radiation therapy. Cancer 1990; 65:2494-6.
43. Zinzani PL, Gherlinzoni F, Piovaccari G, et al. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. Haematologica, in press.
44. Prosnitz LR. Hodgkin's disease; the right dose. Int J Radiat Oncol Biol Phys 1990; 19:803-4.
45. Boivin JF, O' Brien K. Solid cancer risk after treatment of Hodgkin's disease. Cancer 1988; 61:2541-6.
46. Henry Amar M. Quantitative risk of second cancer in patients in first complete remission from early stage of Hodgkin's disease. NCI Monogr 1988; 6:65-72.
47. Valagussa P, Santoro A, Fossati Bellani F, et al. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 1986; 4:830-7.
48. Donaldson SS. Hodgkin's disease in children. Semin Oncol 1990; 17:736-48.
49. Vecchi V, Pileri S, Burnelli R, et al. Treatment of pediatric Hodgkin's disease tailored to stage, mediastinal mass, and age. Cancer 1993; 72:2049-57.
50. Bates NP, Williams MV, Bessell EM, et al. Efficacy and toxicity of vinblastine, bleomycin and methotrexate with involved field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study. J Clin Oncol 1994; 12:288-96